1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Relapsed or Refractory B-cell Lymphoma: new trials by email Literature Review of Relapsed or Refractory B-cell Lymphoma trials Research Report on Relapsed or Refractory B-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CART-19 Cells for R/R B-cell Lymphoma CART-19 cells - Relapsed or Refractory B-cell Lymphoma | Phase 2 / Phase 3 | Unknown | Fujian Medical University | 20 | 2016-01-01 | 2018-01-05 |
Lymphoma, B-Cell (1) · Recurrence (1)
Disease Attributes (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
China (1)